References
1. Pieper K, Grimbacher B, Eibel H.
B-cell biology and development. J Allergy Clin Immunol
2013;131(4):959-971.
2. AL D. The complexity of signaling
pathways activated by the BCR. Curr Opin Immunol 1997;9(3):296-308.
3. Dal Porto JM, Gauld SB, Merrell KT,
et al. B cell antigen receptor signaling 101. Mol Immunol
2004;41(6-7):599-613.
4. Kurosaki T. Regulation of BCR
signaling. Mol Immunol 2011;48(11):1287-1291.
5. Huang L, Zhang Y, Xu C, et al.
Rictor positively regulates B cell receptor signaling by modulating
actin reorganization via ezrin. PLoS Biol 2017;15(8):e2001750.
6. Tolar P. Cytoskeletal control of B
cell responses to antigens. Nat Rev Immunol 2017;17(10):621-634.
7. Loyher PL, Rochefort J, Baudesson
de Chanville C, et al. CCR2 Influences T Regulatory Cell Migration to
Tumors and Serves as a Biomarker of Cyclophosphamide Sensitivity. Cancer
Res 2016;76(22):6483-6494.
8. Zhang N, Schroppel B, Lal G, et al.
Regulatory T cells sequentially migrate from inflamed tissues to
draining lymph nodes to suppress the alloimmune response. Immunity
2009;30(3):458-469.
9. Frade JM, Mellado M, del Real G, et
al. Characterization of the CCR2 chemokine receptor: functional CCR2
receptor expression in B cells. J Immunol 1997;159(11):5576-5584.
10. Legler DF, Loetscher M, Roos RS,
et al. B cell-attracting chemokine 1, a human CXC chemokine expressed in
lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J
Exp Med 1998;187(4):655-660.
11. Sato N, Ahuja SK, Quinones M, et
al. CC chemokine receptor (CCR)2 is required for langerhans cell
migration and localization of T helper cell type 1 (Th1)-inducing
dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant
phenotype to a susceptible state dominated by Th2 cytokines, b cell
outgrowth, and sustained neutrophilic inflammation. J Exp Med
2000;192(2):205-218.
12. Flaishon L, Becker-Herman S, Hart
G, et al. Expression of the chemokine receptor CCR2 on immature B cells
negatively regulates their cytoskeletal rearrangement and migration.
Blood 2004;104(4):933-941.
13. Shah M, Edman MC, Janga SR, et
al. A rapamycin-binding protein polymer nanoparticle shows potent
therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse
model of Sjogren’s syndrome. J Control Release 2013;171(3):269-279.
14. Cejka D, Hayer S, Niederreiter B,
et al. Mammalian target of rapamycin signaling is crucial for joint
destruction in experimental arthritis and is activated in osteoclasts
from patients with rheumatoid arthritis. Arthritis Rheum
2010;62(8):2294-2302.
15. Perl A. Activation of mTOR
(mechanistic target of rapamycin) in rheumatic diseases. Nat Rev
Rheumatol 2016;12(3):169-182.
16. Guo YC, Zhang M, Wang FX, et al.
Macrophages Regulate Unilateral Ureteral Obstruction-Induced Renal
Lymphangiogenesis through C-C Motif Chemokine Receptor 2-Dependent
Phosphatidylinositol 3-Kinase-AKT-Mechanistic Target of Rapamycin
Signaling and Hypoxia-Inducible Factor-1alpha/Vascular Endothelial
Growth Factor-C Expression. Am J Pathol 2017;187(8):1736-1749.
17. Park E, Kim MS, Song JH, et al.
MST1 deficiency promotes B cell responses by CD4(+) T cell-derived IL-4,
resulting in hypergammaglobulinemia. Biochem Biophys Res Commun
2017;489(1):56-62.
18. Ueda Y, Katagiri K, Tomiyama T,
et al. Mst1 regulates integrin-dependent thymocyte trafficking and
antigen recognition in the thymus. Nat Commun 2012;3:1098.
19. Bai X, Huang L, Niu L, et al.
Mst1 positively regulates B-cell receptor signaling via CD19
transcriptional levels. Blood Adv 2016;6(1):219-230.
20. Alunno A, Padjen I, Fanouriakis
A, et al. Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in
Systemic Lupus Erythematosus: Integration of Distinct Inflammatory
Pathways and the Prospect of Their Inhibition with an Oral Agent. Cells
2019;8(8).
21. Mellado M, Rodríguez-Frade JM,
Aragay A, et al. The chemokine monocyte chemotactic protein 1 triggers
Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B
receptor. Journal of immunology 1998;161(2):805-813.
22. Biswas SK, A S. Tyrosine
phosphorylation-mediated signal transduction in MCP-1-induced macrophage
activation: role for receptor dimerization, focal adhesion protein
complex and JAK/STAT pathway. Int Immunopharmacol 2002;2(8):1095-1107.
23. Jing Y, Kang D, Liu L, et al.
Dedicator of cytokinesis protein 2 couples with lymphoid
enhancer-binding factor 1 to regulate expression of CD21 and B-cell
differentiation. J Allergy Clin Immunol 2019;144(5):1377-1390 e1374.
24. Dahlberg CI, Torres ML, Petersen
SH, et al. Deletion of WASp and N-WASp in B cells cripples the germinal
center response and results in production of IgM autoantibodies. J
Autoimmun 2015;62:81-92.
25. Johnson JL, Rosenthal RL, Knox
JJ, et al. The Transcription Factor T-bet Resolves Memory B Cell Subsets
with Distinct Tissue Distributions and Antibody Specificities in Mice
and Humans. Immunity 2020;52(5):842-855 e846.
26. Scharenberg AM, Humphries LA,
Rawlings DJ. Calcium signalling and cell-fate choice in B cells. Nat Rev
Immunol 2007;7(10):778-789.
27. Caro-Maldonado A, Wang R, Nichols
AG, et al. Metabolic reprogramming is required for antibody production
that is suppressed in anergic but exaggerated in chronically
BAFF-exposed B cells. J Immunol 2014;192(8):3626-3636.
28. Kojima H, Kobayashi A, Sakurai D,
et al. Differentiation stage-specific requirement in hypoxia-inducible
factor-1alpha-regulated glycolytic pathway during murine B cell
development in bone marrow. J Immunol 2010;184(1):154-163.
29. Gnanaprakasam JNR, Sherman JW,
Wang R. MYC and HIF in shaping immune response and immune metabolism.
Cytokine Growth Factor Rev 2017;35:63-70.
30. Teng KY, Han J, Zhang X, et al.
Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an
Effective Therapy for Hepatocellular Cancer in a Mouse Model. Mol Cancer
Ther 2017;16(2):312-322.
31. Chao Y, Wang Y, Liu X, et al.
Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling
pathway. J Neurooncol 2015;121(2):279-288.
32. Shi H, Liu C, Tan H, et al. Hippo
Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in
Regulatory T Cells to Establish Stable Regulatory Activity. Immunity
2018;49(5):899-914 e896.
33. Perl A. mTOR activation is a
biomarker and a central pathway to autoimmune disorders, cancer,
obesity, and aging. Ann N Y Acad Sci 2015;1346(1):33-44.
34. Di Liberto G, Pantelyushin S,
Kreutzfeldt M, et al. Neurons under T Cell Attack Coordinate
Phagocyte-Mediated Synaptic Stripping. Cell 2018;175(2):458-471 e419.
35. Corcione A, Tortolina G, Bonecchi
R, et al. Chemotaxis of human tonsil B lymphocytes to CC chemokine
receptor (CCR) 1, CCR2 and CCR4 ligands is restricted to non-germinal
center cells. Int Immunol 2002;14(8):883-892.